USPTO serial 97269558
GENOME360
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 10, 2024
- Examiner
- UKAOMA, ULOMA JANET
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENOME360?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Cambridge, MA
Cambridge, MA
Cambridge, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher A. Proskey
Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVENUE, STE 2000DES MOINES, IA 50309United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business services provided to the healthcare industry, namely, evaluation and systemization of testing results for medical data analysis into computer databases; medical data testing assessment services, and patient identification services in the nature of storing and analyzing patient data; medical data testing assessment services for systemization of information into computer databases, clinical trial development services in the nature of management and compilation of computerized databases in the field of clinical trials for business purposes; research study development services in the nature of management and compilation of computerized databases in the field of healthcare for business purposes; standard of care business development services, and data analysis services in the field of healthcare; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Collection and analysis of quality clinical and empirical data for a network of health care providers for business purposes; none of the foregoing services in the fields of genetics, genetics testing, or business analytics of genetics testing | ACTIVE | Jan 13, 2020 |
| 042 | Software as a service (SAAS) services featuring software for use in the collection and analysis of healthcare data and healthcare information; Platform as a service featuring computer software platforms, namely, data application platform to store and analyze patient data in the healthcare industry; computer services, namely, providing computer software as a service (SaaS) featuring software for identifying, collecting, managing, analyzing, segmenting, retrieving, monitoring, maintaining, reporting on, structuring, modeling, forecasting, presenting and displaying healthcare data and healthcare information; computer services, namely, providing platforms as a service (PaaS) featuring computer software for creating web applications, data storage and backup, database management, virtualization, networking, collaboration, information access, customer service and support, cloud computing, data sharing, data security, all in the field of healthcare data and healthcare information; computer services, namely, providing platforms as a service (PaaS) featuring computer software for administration and management of, and distribution and transmission of healthcare data and healthcare information; computer services, namely, providing databases as a service (DBaaS), namely, cloud hosting of computer databases for others and providing online non-downloadable software for database management and data analytics, all in the healthcare industry; computer services, namely, providing data as a service through a customizable software platform for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; computer services, namely, providing data as a service to the healthcare industry through a customizable software platform for collecting, analyzing, segmenting, integrating, transforming and providing access to healthcare data and healthcare information; data as a service (DAAS) services, namely, providing online non-downloadable software for accessing healthcare related data through an electronic computer network; data as a service (DaaS) services, namely, providing online non-downloadable software for use in the collection and analysis of healthcare data and healthcare information; application service provider (ASP) services featuring software for use in the collection and analysis of healthcare data and healthcare information; application service provider featuring non-downloadable application programming interface (API) software for use in the collection and analysis of healthcare data and healthcare information; data as a service (DaaS) services through a customizable software platform for collecting, analyzing, integrating, transforming and providing access to healthcare data and healthcare information; Clinical trial development services, namely, conducting research and clinical trials for others relating to healthcare | ACTIVE | Jan 13, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 10, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 10, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 6, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 6, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 6, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 6, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 22, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 22, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 22, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 22, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 5, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 6, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 6, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 6, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 19, 2022 | NWAP | NEW APPLICATION ENTERED | — |